Patients in northwestern turkey prefer herbs as complementary medicine after breast cancer diagnosis

Breast Care

Volumn 3, Issue 4, 2008, Pages 269-273

  Gulluoglu, Bahadir M ^a   Cingi, Asim ^a   Cakir, Tebessum ^a   Barlas, Afsar ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Complementary medicine; Supportive care; Therapy

Indexed keywords

CAMPHOR; CHAMOMILE; HERBACEOUS AGENT; LINSEED OIL;

ACHILLEA; ACUPUNCTURE; ADULT; AGED; ALOE VERA; ALTERNATIVE MEDICINE; AROMATHERAPY; ARTICLE; ATTITUDE; BLACK CUMIN; BREAST CANCER; BROCCOLI; CANCER DIAGNOSIS; CARROT; CLINICAL STUDY; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FEMALE; GINSENG; GRAPE; HEALTH STATUS; HEALTH SURVEY; HERBAL MEDICINE; HIBISCUS; HONEY; HUMAN; LATHYRUS; MAJOR CLINICAL STUDY; MALVA; MASSAGE; MEDITATION; MUSIC THERAPY; NUTRITIONAL SUPPORT; ORANGE (FRUIT); OUTCOME ASSESSMENT; PATIENT SATISFACTION; POLLEN; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; TEA; TIME SERIES ANALYSIS; TREATMENT OUTCOME; URTICA DIOICA;

EID: 51849159573     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000144045     Document Type: Article

References (21)

1. Ernst E, Cassileth BR: The prevalence of complementary/ alternative medicine in cancer: a systematic review. Cancer 1998;83:777-82.
2. Catt S, Fallowfield L, Langridge C: What non-prescription treatments do UK women with breast cancer use? Eur J Cancer Care 2006;15:279-85.
3. Rakovitch E, Pignol JP, Chartier C, Ezer M, Verma S, Dranitsaris G, Clemons M: Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 2005;90:139-48.
4. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T:The use of complementary/ alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000;18:2515-21.
5. Burstein HJ, Gelber S, Guadagnoli E, Weeks J: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-9.
6. Ashikaga T, Bosompra K, O'Brien P, Nelson L: Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 2002;10:542-8.
7. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE: Complementary/alternative medicine use in a comprehensive cancer centre and the implications of oncology. J Clin Oncol 2000;18:2505-14.
8. Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005;16:655-63.
9. Hawks JH, Moyad MA: CAM: Definition and classification overview. Urol Nurs 2003;23:221-3.
10. Tagliaferri M, Cohen I, Tripathy D: Complementary and alternative medicine in early-stage breast cancer. Semin Oncol 2001;28:121-34.
11. Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C: Prevalence of complementary therapy use by women with breast cancer: a population-based study. Eur J Cancer 2000;36:1359-64.
12. Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, Karagol H, Sakar B, Disci R, Topuz E: The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol 2005;44:161-7.
13. Isikhan V, Komurcu S, Ozet A, Arpaci F, Ozturk B, Balbay O, Guner P: The status of alternative treatment in cancer patients in Turkey. Cancer Nurs 2005;28:355-62.
14. Algier LA, Hanoglu Z, Ozden G, Kara F: The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs 2005;9:138-46.
15. Karadeniz C, Pinarli FG, Oguz A, Gursel T, Canter B: Complementary / alternative medicine use in a pediatric oncology unit in Turkey. Pediatr Blood Cancer 2007;48:540-3.
16. Eustachi E: Complementary therapies in breast cancer patients. Breast Care 2007;2:209-16.
17. Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, Shekelle P: Use of complementary / alternative therapies by women with advanced stage breast cancer. BMC Complement Altern Med 2002;2:8.
18. Rodriguez-Fragoso L, Reyes-Esparaza J, Burchiel SW, Herrera-Ruiz D, Torres E: Risks and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol 2008;227:125-35.
19. Helyer LK, Chin S, Chui BK, Fitzgerald B, Verma S, Rakovitch E, Dranitsaris G, Clemons M: The use of complementary and alternative medicines among patients with locally advanced breast cancer - a descriptive study. BMC Cancer 2006;6:39.
20. Risberg T, Kolstad A, Bremmes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR: Knowledge of and attitudes toward complementary and alternative therapies: a national multicentre study of oncology professionals in Norway. Eur J Cancer 2004;40:529-35.
21. Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W: Use of complementary and alternative medicine by chinese women with breast cancer. Breast Cancer Res Treat 2004;85:263-70.